Elena Kraus is leaving Walgreens, where she served for six years as senior vice president and general counsel, to join Whataburger as executive vice president and chief legal officer.
Upon completion of the distribution, Embecta will be an independent and publicly traded company focused on diabetes management that BD will retain no ownership interest.
Haleon will focus 100% on consumer health, with a portfolio of brands including Sensodyne, Panadol, Advil, Voltaren Theraflu, Otrivin and Centrum, the company said.
The sale reportedly will lead to the dismantling of the Walgreens Boots Alliance, which was set up in 2014 when Walgreens took full control of the health and beauty chain.